The leadership at the PolicyBazaar group is relieved. Several sources have confirmed that the group will soon sell a majority stake in DocPrime, the virtual doctor consultation platform it launched in late 2018. It isn’t that DocPrime is a lost cause. Or even truly struggling. It was just an odd duck for an entity that, as a senior executive with the group tells it, does not invest in something without a clear sense of when it will make money. “It’s just not in our DNA,” the executive says simply.
When DocPrime was announced, it was seen as a fine addition to the PolicyBazaar group.